Ryerson tries new flu drug
February 9, 2000
Relenza, a flu medication recently approved for use in Canada, has been criticized by experts at the U.S. Food and Drug Administration and Britain’s National Institute for Clinical Excellence, where the drug is also available, for having little impact on symptoms and uncertain long term effects.



